Jan Levesque
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AstraZeneca at 26.1% of the total. Among family clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $27.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$765
- Novo Nordisk$355
- Abbott$321
- Lilly USA, LLC$300
- Tandem Diabetes Care, Inc.$193
- GSK$137
- plus $858 from 16 others
What the payments were for
- Food & beverage$2,929100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 40 | $765 |
| Novo Nordisk | 14 | $355 |
| Abbott | 5 | $321 |
| Lilly USA, LLC | 16 | $300 |
| Tandem Diabetes Care, Inc. | 4 | $193 |
| GSK | 3 | $137 |
| Amgen | 1 | $120 |
| Bayer | 2 | $119 |
| Sanofi-aventis U.S. LLC | 4 | $112 |
| AbbVie | 2 | $68 |
| Sequel Med Tech, LLC | 1 | $67 |
| BETA Bionics, Inc. | 1 | $55 |
| Merck | 2 | $52 |
| Boehringer Ingelheim | 2 | $50 |
| Collegium Pharmaceutical, Inc. | 2 | $46 |
| Medtronic | 1 | $45 |
| Abiomed | 1 | $32 |
| Pfizer | 1 | $24 |
| Insulet Corporation | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Exact Sciences | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$181
- t:slim X2 Insulin Pump with Control-IQ$149
- TEPEZZA$120
- FreeStyle Libre 2$108
- Kerendia$103
- SHINGRIX$103
How this compares
$2,929 in reported general payments places this provider in the 95th percentile of 713 family providers in New Hampshire.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 37 | $52,745 |
| JardianceEmpagliflozin | 33 | $30,072 |
| MounjaroTirzepatide | 22 | $29,435 |
| TrulicityDulaglutide | 13 | $24,941 |
| FarxigaDapagliflozin Propanediol | 17 | $23,555 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 15 | $12,577 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $9,857 |
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 12 | $1,815 |
| Metformin Hcl ErMetformin Hcl | 23 | $405 |
| Atorvastatin Calcium | 27 | $263 |
| Lisinopril | 19 | $86 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $300 | $54,37635 claims |
| Novo NordiskOzempic | $355 | $52,74537 claims |
| Boehringer IngelheimJardiance | $50 | $30,07233 claims |
| AstraZenecaFarxiga | $765 | $23,55517 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $112 | $12,57715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 713 family providers in New Hampshire.
Other family in Derry
- Summer BellDerry$16K
- Lauren AbbottDerry$6K
- Allison AnastasoffDerry$4K
- Jenna ClarkDerry$3K
- Tara Delle ChiaieHampton$548K
- Wendy WrightAmherst$447K
- Richard CareyNashua$51K
- Laura HudsonDover$14K
- Debra KrisonNorth Hampton$13K
- Michelle WhiteBedford$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.